Literature DB >> 19032178

Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials.

Zhiguo Li1, Peter Gilbert, Bin Nan.   

Abstract

SUMMARY: Grouped failure time data arise often in HIV studies. In a recent preventive HIV vaccine efficacy trial, immune responses generated by the vaccine were measured from a case-cohort sample of vaccine recipients, who were subsequently evaluated for the study endpoint of HIV infection at prespecified follow-up visits. Gilbert et al. (2005, Journal of Infectious Diseases 191, 666-677) and Forthal et al. (2007, Journal of Immunology 178, 6596-6603) analyzed the association between the immune responses and HIV incidence with a Cox proportional hazards model, treating the HIV infection diagnosis time as a right-censored random variable. The data, however, are of the form of grouped failure time data with case-cohort covariate sampling, and we propose an inverse selection probability-weighted likelihood method for fitting the Cox model to these data. The method allows covariates to be time dependent, and uses multiple imputation to accommodate covariate data that are missing at random. We establish asymptotic properties of the proposed estimators, and present simulation results showing their good finite sample performance. We apply the method to the HIV vaccine trial data, showing that higher antibody levels are associated with a lower hazard of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032178     DOI: 10.1111/j.1541-0420.2008.00998.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  10 in total

1.  Outcome-dependent sampling with interval-censored failure time data.

Authors:  Qingning Zhou; Jianwen Cai; Haibo Zhou
Journal:  Biometrics       Date:  2017-08-03       Impact factor: 2.571

2.  Sample size calculation for studies with grouped survival data.

Authors:  Zhiguo Li; Xiaofei Wang; Yuan Wu; Kouros Owzar
Journal:  Stat Med       Date:  2018-06-10       Impact factor: 2.373

3.  In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities.

Authors:  Holly Janes; Peter Gilbert; Susan Buchbinder; James Kublin; Magdalena E Sobieszczyk; Scott M Hammer
Journal:  AIDS Res Hum Retroviruses       Date:  2013-06-25       Impact factor: 2.205

Review 4.  Recent progresses in outcome-dependent sampling with failure time data.

Authors:  Jieli Ding; Tsui-Shan Lu; Jianwen Cai; Haibo Zhou
Journal:  Lifetime Data Anal       Date:  2016-01-13       Impact factor: 1.588

5.  Case-cohort studies with interval-censored failure time data.

Authors:  Q Zhou; H Zhou; J Cai
Journal:  Biometrika       Date:  2017-02-03       Impact factor: 2.445

6.  A general semiparametric Z-estimation approach for case-cohort studies.

Authors:  Bin Nan; Jon A Wellner
Journal:  Stat Sin       Date:  2013-07-01       Impact factor: 1.261

7.  Semiparametric inference for a two-stage outcome-dependent sampling design with interval-censored failure time data.

Authors:  Qingning Zhou; Jianwen Cai; Haibo Zhou
Journal:  Lifetime Data Anal       Date:  2019-01-07       Impact factor: 1.588

8.  Analysis of two-phase sampling data with semiparametric additive hazards models.

Authors:  Yanqing Sun; Xiyuan Qian; Qiong Shou; Peter B Gilbert
Journal:  Lifetime Data Anal       Date:  2016-03-19       Impact factor: 1.588

9.  A global logrank test for adaptive treatment strategies based on observational studies.

Authors:  Zhiguo Li; Marcia Valenstein; Paul Pfeiffer; Dara Ganoczy
Journal:  Stat Med       Date:  2013-09-20       Impact factor: 2.373

10.  Semiparametric regression analysis of case-cohort studies with multiple interval-censored disease outcomes.

Authors:  Qingning Zhou; Jianwen Cai; Haibo Zhou
Journal:  Stat Med       Date:  2021-03-29       Impact factor: 2.373

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.